Destabilizing HDGF through NSUN2-YBX1 signaling inhibition for bladder cancer

DISEASE CATEGORY: Cancer

INDICATION: Bladder cancer

Destabilizing the oncogene HDGF by inhibiting NSUN2-YBX1 signaling could treat bladder cancer. In 199 bladder cancer

Read the full 207 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE